Latest Lilly Stories
INDIANAPOLIS, Oct. 3, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its financial results for the third quarter of 2014 on Thursday, October 23, 2014.
INDIANAPOLIS, Sept. 29, 2014 /PRNewswire/ -- On Oct. 2, some 24,000 Lilly employees spanning nearly 60 countries will participate in the company's seventh Global Day of Service.
- Trulicity, a weekly glucagon-like peptide-1 (GLP-1) receptor agonist, is indicated for adults with type 2 diabetes as an adjunct to diet and exercise INDIANAPOLIS, Sept.
-- Phase III RAINBOW Trial Data Published in The Lancet Oncology -- INDIANAPOLIS, Sept.
Company announces a series of digital and employee initiatives honoring women INDIANAPOLIS, Sept.
-- Ramucirumab Plus FOLFIRI Improved Survival in Metastatic Colorectal Cancer following Progression on a Bevacizumab-Based Regimen -- INDIANAPOLIS, Sept.
INDIANAPOLIS, Sept. 9, 2014 /PRNewswire/ -- Fifty abstracts designed to advance knowledge in diabetes science will be presented Sept.
- totally perplexed and mixed up.